Clinical trials data
Trail Making Test in cardiovascular trials: 105 registered studies
Every registered cardiovascular disease study on ClinicalTrials.gov that names the Trail Making Test in an outcome measure: how often it is a primary outcome, the tests named with it, how large the studies are and when they measure it.
- Registered cardiovascular disease studies name it in an outcome measure
- 105
- Name it in a primary outcome, 30%
- 32 of 105
Tests named in the same studies
- 1
Digit Span Test32 studies, 11 as a primary outcome
- 2
Verbal Learning31 studies, 12 as a primary outcome
- 3
Stroop Color-Word Test29 studies, 11 as a primary outcome
- 4
Verbal Fluency29 studies, 10 as a primary outcome
- 5
Symbol Coding27 studies, 5 as a primary outcome
- 6
Category Fluency18 studies, 8 as a primary outcome
- 7
Task Switching Test10 studies, 4 as a primary outcome
- 8
Picture Naming Test10 studies, 3 as a primary outcome
- 9
N-Back Task7 studies, 4 as a primary outcome
- 10
Clock Drawing Task7 studies, 1 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
Studies by start year
A test as a primary outcomeOnly in secondary or other outcomes
Show as a table
| Start year | Studies | A test as a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 1 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 1 |
| 2009 | 0 | 0 |
| 2010 | 2 | 1 |
| 2011 | 2 | 1 |
| 2012 | 1 | 1 |
| 2013 | 3 | 2 |
| 2014 | 5 | 2 |
| 2015 | 4 | 0 |
| 2016 | 8 | 3 |
| 2017 | 3 | 1 |
| 2018 | 6 | 2 |
| 2019 | 8 | 2 |
| 2020 | 7 | 6 |
| 2021 | 7 | 0 |
| 2022 | 9 | 1 |
| 2023 | 13 | 2 |
| 2024 | 8 | 2 |
| 2025 | 6 | 3 |
| 2026 | 11 | 2 |
Phases and study sizes
By phase
- Early phase 12 studies, 0 as a primary outcome
- Phase 11 studies, 0 as a primary outcome
- Phase 1/21 studies, 1 as a primary outcome
- Phase 28 studies, 3 as a primary outcome
- Phase 2/31 studies, 0 as a primary outcome
- Phase 31 studies, 0 as a primary outcome
- Phase 46 studies, 0 as a primary outcome
- Not applicable64 studies, 20 as a primary outcome
- Observational21 studies, 8 as a primary outcome
Participants per study
- Not applicable100 median, 43 to 153
- Observational135 median, 79 to 515
Show as a table
| Phase | Studies with a size | Median | Middle half |
|---|---|---|---|
| Not applicable | 63 | 100 | 43 to 153 |
| Observational | 20 | 135 | 79 to 515 |
When cardiovascular trials measure it
Latest time point of each outcome
- Within a day7 outcomes, 3 as a primary outcome
- Up to 4 weeks10 outcomes, 4 as a primary outcome
- 1 to 3 months21 outcomes, 5 as a primary outcome
- 3 to 6 months20 outcomes, 4 as a primary outcome
- 6 to 12 months23 outcomes, 8 as a primary outcome
- 1 to 2 years10 outcomes, 3 as a primary outcome
- Over 2 years8 outcomes, 2 as a primary outcome
- No duration given6 outcomes, 3 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
99 of the 105 outcome measures give a duration. A single visit counts as within a day.
Status, results, interventions and countries
Status
- Recruiting21 studies, 5 as a primary outcome
- Not yet recruiting6 studies, 2 as a primary outcome
- Active, not recruiting6 studies, 0 as a primary outcome
- Completed41 studies, 19 as a primary outcome
- Stopped early6 studies, 3 as a primary outcome
- Status unknown25 studies, 3 as a primary outcome
What they test
- Behavioral26 studies, 5 as a primary outcome
- Drug26 studies, 4 as a primary outcome
- Device13 studies, 2 as a primary outcome
- Dietary supplement5 studies, 2 as a primary outcome
- Procedure17 studies, 5 as a primary outcome
- Diagnostic test5 studies, 0 as a primary outcome
- Biological1 studies, 0 as a primary outcome
- Other23 studies, 10 as a primary outcome
- None given10 studies, 5 as a primary outcome
Intervention types as registered. A study can list several; observational studies often list none.
Where their sites are
- United States31 studies, 11 as a primary outcome
- Canada12 studies, 3 as a primary outcome
- China10 studies, 0 as a primary outcome
- Spain7 studies, 2 as a primary outcome
- Switzerland6 studies, 1 as a primary outcome
- France4 studies, 0 as a primary outcome
- Sweden4 studies, 2 as a primary outcome
- Brazil3 studies, 1 as a primary outcome
- Denmark3 studies, 1 as a primary outcome
- United Kingdom3 studies, 0 as a primary outcome
- Australia2 studies, 0 as a primary outcome
- Germany2 studies, 1 as a primary outcome
23 countries in all. A study with sites in several counts in each; 8 list no site.
Reported results
Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.
Completed cardiovascular disease studies that name the Trail Making Test: 22 of 41, 54%
Every completed study with a cognitive outcome: 3,626 of 7,953, 46%
| Results | Completed cardiovascular disease studies that name the Trail Making Test | Every completed study |
|---|---|---|
| Results on ClinicalTrials.gov and a paper | 6, 15% | 776, 10% |
| Results on ClinicalTrials.gov only | 5, 12% | 1,139, 14% |
| A results paper only | 11, 27% | 1,711, 22% |
| Neither | 19, 46% | 4,327, 54% |
The 105 studies
105 studies match. 32 name the Trail Making Test in a primary outcome. Median size 101 participants. Median time to the primary outcome: 6 months.
Loading 105 studies; the filters turn on when they arrive.
2026 is partly planned starts.
Show as a table
| Start year | Studies | As a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 1 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 1 |
| 2009 | 0 | 0 |
| 2010 | 2 | 1 |
| 2011 | 2 | 1 |
| 2012 | 1 | 1 |
| 2013 | 3 | 2 |
| 2014 | 5 | 2 |
| 2015 | 4 | 0 |
| 2016 | 8 | 3 |
| 2017 | 3 | 1 |
| 2018 | 6 | 2 |
| 2019 | 8 | 2 |
| 2020 | 7 | 6 |
| 2021 | 7 | 0 |
| 2022 | 9 | 1 |
| 2023 | 13 | 2 |
| 2024 | 8 | 2 |
| 2025 | 6 | 3 |
| 2026 | 11 | 2 |
Library tests named most
Largest condition groups
Phases
Participants
Lead sponsor: industry 2, other 103. Interventional 84, observational 21.
As a primary outcomeSecondary or other outcomeThe Trail Making Test
The studies, newest registration first
Each number opens the study's record on ClinicalTrials.gov.
| Study | Start | Phase | Conditions | Participants | Lead sponsor | Status | Library tests named, with the latest time point |
|---|---|---|---|---|---|---|---|
| NCT07882875 | Start2026 | PhaseObservational | ConditionsStroke, Cardiovascular disease | Participants560 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07856043 | Start2026 | PhasePhase 1 | ConditionsDementia and Alzheimer's, Mild cognitive impairment, Cardiovascular disease | Participants18 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07695090 | Start2026 | PhasePhase 2 | ConditionsCardiovascular disease | Participants60 | Lead sponsorIndustry | StatusRecruiting | Library tests named
|
| NCT07692958 | Start2026 | PhaseNot applicable | ConditionsCardiovascular disease | Participants160 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07689500 | Start2025 | PhaseNot applicable | ConditionsDelirium, surgery and intensive care, Cardiovascular disease | Participants153 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07666685 | Start2026 | PhaseNot applicable | ConditionsAging, frailty and exercise, Cardiovascular disease | Participants120 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07664748 | Start2026 | PhaseNot applicable | ConditionsCardiovascular disease | Participants60 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07648498 | Start2026 | PhaseNot applicable | ConditionsCardiovascular disease | Participants30 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07633392 | Start2026 | PhaseNot applicable | ConditionsAging, frailty and exercise, Substance use and addiction, Sleep and sleep disorders, Cardiovascular disease | Participants240 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07626567 | Start2026 | PhaseObservational | ConditionsDelirium, surgery and intensive care, Cardiovascular disease | Participants500 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07259434 | Start2026 | PhaseNot applicable | ConditionsCancer, Cardiovascular disease | Participants152 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07204834 | Start2025 | PhaseNot applicable | ConditionsCardiovascular disease | Participants200 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06945848 | Start2026 | PhaseNot applicable | ConditionsCancer, Pain and fatigue, Cardiovascular disease | Participants114 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06919744 | Start2025 | PhaseNot applicable | ConditionsCancer, Pain and fatigue, Cardiovascular disease | Participants114 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06857994 | Start2025 | PhaseObservational | ConditionsObesity and diabetes, Cardiovascular disease | Participants101 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06855953 | Start2025 | PhaseNot applicable | ConditionsCardiovascular disease | Participants40 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT06781541 | Start2022 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Aging, frailty and exercise, Obesity and diabetes, Cardiovascular disease | Participants72 | Lead sponsorOther | StatusActive, not recruiting | Library tests named
|
| NCT06743711 | Start2025 | PhaseObservational | ConditionsSchizophrenia and psychosis, Depression and bipolar disorder, Cardiovascular disease | Participants75 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06697418 | Start2024 | PhaseObservational | ConditionsCardiovascular disease | Participants266 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06529055 | Start2024 | PhaseNot applicable | ConditionsPain and fatigue, Cardiovascular disease | Participants20 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT06512922 | Start2024 | PhaseNot applicable | ConditionsAging, frailty and exercise, Cardiovascular disease | Participants120 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06477107 | Start2024 | PhaseNot applicable | ConditionsCardiovascular disease | Participants7 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06469515 | Start2024 | PhaseObservational | ConditionsDelirium, surgery and intensive care, Cardiovascular disease | Participants220 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06307483 | Start2023 | PhaseObservational | ConditionsSleep and sleep disorders, Cardiovascular disease | Participants499 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06242535 | Start2023 | PhaseEarly phase 1 | ConditionsDepression and bipolar disorder, Aging, frailty and exercise, Obesity and diabetes, Cardiovascular disease | Participants13 | Lead sponsorIndustry | StatusCompleted | Library tests named
|
Questions, answered from the data
How many cardiovascular trials use the Trail Making Test?
105 registered cardiovascular disease studies on ClinicalTrials.gov name it in an outcome measure, 32 of them in a primary outcome: 15% of the condition's 682 studies with a cognitive outcome, against 14% of all of them. It is the test cardiovascular trials name most.
Which tests do cardiovascular trials use with the Trail Making Test?
The Digit Span Test (32 studies), Verbal Learning (31 studies) and the Stroop Color-Word Test (29 studies).
When do cardiovascular trials measure the Trail Making Test?
Half of the primary outcomes that name the Trail Making Test are measured within 6 months of the start, and the middle half from 8 weeks to 12 months. 29 primary outcomes give a duration.
How many completed cardiovascular trials that use the Trail Making Test have reported results?
22 of the 41 completed studies that name it, 54%, have reported results: 11 posted them on ClinicalTrials.gov, 17 have a results paper linked to the registry record, and 6 did both. The other 19 show neither. Of all completed studies with a cognitive outcome, 46% have reported results.
How the studies are counted
For each test family, the census runs ClinicalTrials.gov's own outcome search for the family's names and reads every study first posted by the day the family was counted. These studies were read on 10 November 2026. A study counts once on a page, however many tests it names. Counts for a test cover every version of the task under any of its names, so a page can count studies that used a commercial version.
The census adds two things to each record and changes nothing in it: which outcome list names the test (primary, then secondary, then other), and the condition groups, matched on the study's condition names and MeSH terms. A study can fall in several groups; one whose only condition is cognitive impairment or decline falls in “Cognitive impairment and decline”. Studies that name only instruments outside the library count in every total and share but are not listed.
A second read on 10 November 2026 added each study's overall status, whether results are posted, its intervention types, the countries of its sites and the time frame of the outcome that names each test. A time frame counts by the latest time point it names: “Baseline, 12 and 24 weeks” is 24 weeks, a single visit is within a day, and one that names no duration, such as “end of treatment”, is left out of the timings.
A third read on 10 November 2026 added the papers the registry links to each study: those its sponsor lists as reporting results, and those PubMed links to it through the study's NCT number. A study has a results paper when one of them came out in or after the month of its primary completion and PubMed does not class it as a protocol, review or comment. A paper that never gives the NCT number is not linked, so some studies counted as reporting neither did publish.
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine, which does not endorse these pages. Every study line is in the data release 2.1.0, and the explorer's own file is clinical-trials-studies.json.
The census counts Trail Making Test A and Trail Making Test B as one test family, so this page counts their studies together.
Run the Trail Making Test in your trial
Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.